Skip to main content

BY GRADIENCE HEALTH™

QSMQuantitative susceptibility mapping

FGATIRDeep gray/white matter contrast

Other outputsT1, PD and R2*/T2* maps

STAGE for DBSDeep brain stimulation planning support

STAGE for TBITBI reporting

AI Input LayerA calibrated input layer for AI models

PipelineApplications in development

Quantitative MRI About Gradience

Resource Center

NewsCompany and product announcements

PublicationsPeer-reviewed evidence

ContactTalk to the STAGE team

CONTACT

Talk to the STAGE team.

Request a demo, ask a technical or regulatory question, or start a conversation about bringing STAGE to your site.

Request a Demo

Name

Work email

Organization

How can we help?

We use this information only to respond to your request and to follow up about STAGE. We don't sell or share it with third parties. See our team directly at [email protected] if you'd rather not use this form.

STAGE

BY GRADIENCE HEALTH

SITE

Technology STAGE Outputs Applications Quantitative MRI About Gradience Resource Center

OUTPUTS & APPLICATIONS

QSM FGATIR Other outputs DBS Planning TBI Reporting AI Input Layer Pipeline

UTILITY

Contact News Publications

STAGE™ is a trademark of Spintech Inc (DBA Gradience Health). Quantitative susceptibility mapping is 510(k)-cleared for clinical use. Other outputs and applications support visualization by qualified clinicians and are being evaluated with clinical partners; STAGE does not diagnose or treat disease. All imagery on this page is placeholder material.